AbbVie Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest AbbVie careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Scientist II **New** **USA, Massachusetts, Worcester** 1 additional location USA, Massachusetts Research & Development Requisition #1807524 We are seeking a highly motivated and enthusiastic individ...
Posted: October 14, 2018, 7:10 am
Director, Thought Leader Liaison Location: Sunnyvale, CA \# of Openings: 1 Description Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of l...
Posted: October 14, 2018, 7:01 am
CMC Product Development Director **New** **USA, Massachusetts, Worcester** 2 additional locations USA, MassachusettsUSA Research & Development Requisition #1807517 **The Ideal Candidate Will:** ...
Posted: October 13, 2018, 4:17 am
Associate Director, Affiliate PV Supplier QA & Training **New** **USA, Illinois, Lake County** 1 additional location USA, Illinois Medical Requisition #1807421 Establish and oversee an effective q...
Posted: October 13, 2018, 4:17 am
Labeling Strategist, Manager, Regulatory Affairs Europe (Lake County, IL based) **New** **USA, Illinois, Lake County** 1 additional location USA, Illinois Regulatory Affairs Requisition #1807395 **P...
Posted: October 13, 2018, 4:17 am

Viewing page 1 of 100|Next Page

  Newsfeed | Subscribe  

Law360 (October 12, 2018, 6:58 PM EDT) -- Novartis AG unit Sandoz will get to launch its biosimilar of AbbVie Inc.’s immunosuppressant Humira in the U.S. on Sept. 30, 2023, and in Europe on Tuesday as ...
Posted: October 12, 2018, 4:06 pm
AbbVie, Inc. ABBV announced that it has settled a litigation with Sandoz, the generic arm of Novartis NVS, involving AbbVie’s blockbuster arthritis drug, Humira (adalimumab). The company has ...
Posted: October 12, 2018, 7:13 am
AbbVie has already inked several patent settlements with biosimilar developers looking to take on its megablockbuster Humira, and now the company is back at the deal table with a fourth. In a move tha...
Posted: October 12, 2018, 7:02 am
(Reuters) - Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira. Abbv...
Posted: October 11, 2018, 3:09 pm
AbbVie (NYSE:ABBV) has settled its patent infringement litigation with Novartis (NYSE:NVS) unit Sandoz related to top seller HUMIRA ( adalimumab). Under the terms of the deal, it will grant Sandoz ...
Posted: October 11, 2018, 2:12 pm

Viewing page 1 of 3|Next Page